3rd Quarter - Report

TARPLIN, DOWNS & YOUNG, LLC for VERTEX PHARMACEUTICALS INCORPORATED

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

**see addendum page **, no specific bill, Raising Awareness of Hepatitis C ***, no specific bill, public health funding for Hepatitis, appropriations for the Department of Health and Human Services H.R. 3200, America's Affordable Health Choices Act of 2009 S. 1679, Affordable Health Choices Act S._ America's Healthy Future Act of 2009 H.R. 3090, Health Equity and Accountability Act of 2009, hepatitis awareness and screening

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
ISAAC A FORDJOUR —
LINDA E TARPLIN —
JENNIFER B YOUNG —

Contacted: Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1679 (111th), H.R. 3090 (111th), H.R. 3200 (111th)

Budget/Appropriations BUD

reconciliation instructions, health care reform

LobbyistCovered position, as disclosed
RAISSA H DOWNS Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst.
MICHELLE P EASTON Chief Health Counsel, Sen. Cmte. on Finance;
ISAAC A FORDJOUR —
LINDA E TARPLIN Congressman Billy Tauzin
JENNIFER B YOUNG Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg.

Contacted: SENATE; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.